Hypertension Treatment in Patients with Metabolic Syndrome and/or Type 2 Diabetes Mellitus: Analysis of the Therapy Effectivity and the Therapeutic Inertia in Outpatient Study

Table 1

Most frequently used drugs and associated BP changes.

	Number of patients	Start		Finish		Average decrease of sBP	Average decrease of dBP	SD sBP	SD dBP
		Average sBP	Average dBP	Average sBP	Average dBP
Perindopril	186	154.1	88.5	140.2	80.6	13.9	7.9	22.7	13.7
Nitrendipine	159	165.1	89.7	142.3	77.5	22.8	12.2	29.0	15.4
Amlodipine	142	153.0	88.0	141.0	80.0	12.0	8.0	24.0	14.0
Telmisartan	138	161.8	88.8	140.2	77.6	21.7	11.2	28.9	15.1
Hydrochlorothiazide	133	161.8	89.0	139.2	77.5	22.5	11.5	29.7	15.9
Rilmenidine	123	159.1	90.3	143.9	81.8	15.2	8.5	28.8	15.8
Nebivolol	116	158.3	89.6	141.9	80.8	16.4	8.9	24.5	13.9
Bisoprolol	100	150.0	84.5	138.4	76.8	11.6	7.7	23.1	15.7
Indapamide	98	156.2	88.4	139.4	80.4	16.8	8.0	21.4	12.9
Verapamil	89	157.7	89.4	141.1	79.2	16.6	10.2	24.2	13.6